Cell and Gene Therapy Catapult
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
gptkb:research_institute |
| gptkbp:CEO |
Matthew Durdy
|
| gptkbp:collaboratesWith |
academic institutions
industry partners NHS |
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focus |
gene therapy
|
| gptkbp:founded |
2012
|
| gptkbp:headquarters_location |
gptkb:London
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cell and Gene Therapy Catapult
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mission |
advance cell and gene therapies to market
|
| gptkbp:operates |
manufacturing centre in Stevenage
manufacturing innovation centre in Braintree |
| gptkbp:parentOrganization |
gptkb:Innovate_UK
|
| gptkbp:purpose |
accelerate the growth of the UK cell and gene therapy industry
|
| gptkbp:website |
https://ct.catapult.org.uk/
|
| gptkbp:bfsParent |
gptkb:Catapult_Network
|
| gptkbp:bfsLayer |
7
|